Literature DB >> 22955875

IL-23A, IL-23R, IL-17A and IL-17R polymorphisms in different psoriatic arthritis clinical manifestations in the northern Italian population.

Maria Grazia Catanoso1, Luigi Boiardi, Pierluigi Macchioni, Paolo Garagnani, Marco Sazzini, Sara De Fanti, Enrico Farnetti, Bruno Casali, Ilaria Chiarolanza, Davide Nicoli, Donata Luiselli, Carlo Salvarani.   

Abstract

To investigate the genetic variability of IL-17A, IL17-RA, IL-23A and IL-23R genes on an in-depth phenotypically characterized northern Italian Psoriatic arthritis (PsA) case-control cohort, in search for associations specific to different PsA clinical sub-phenotypes. We examined 118 patients with PsA according to CASPAR criteria (mean age 57 ± 13, female 38.4 %, mean disease duration 13.9 ± 8.6 years, peripheral disease 83.8 %, axial manifestations 34.5 %, radiological erosive disease 49 %) compared with 248 controls of the same ethnic origin matched for age and sex. The presence of axial disease was defined by the clinical axial involvement and/or the presence of radiological alteration consistent with spondyloarthropathy according to New York criteria. The presence of peripheral disease (arthritis and/or enthesitis) was defined only on clinical basis. A total of 40 SNPs, mapping within the genes mentioned above, were genotyped in both groups and used to perform association analyses by subdividing the PsA sample into subgroups according to different clinical manifestations on the basis of axial and peripheral involvements. No differences between patients and controls were found in the distribution of the IL-17A, IL17-RA, IL-23A and IL-23R genes allelic variants. Comparing patients with axial disease versus those without, we found that axial manifestations were significantly associated with the presence of IL-23R rs12401432 GG homozygosity (26.8 % vs. 5.3 %, p corr = 0.019, OR 2.63 [95 % CI 1.13-6.16]). No differences in distribution of the allelic variants were found comparing patients with versus those without peripheral disease or patients with versus without radiological peripheral erosions. In PA patients of northern Italian origin, IL-17A, IL17-RA, IL-23A and IL-23R genes allelic variants are not associated with disease susceptibility. However, a strong association with the IL-23RA rs12401432 GG genotype is associated with axial involvement of the disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22955875     DOI: 10.1007/s00296-012-2501-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  43 in total

1.  Automated genotyping using the DNA MassArray technology.

Authors:  Christian Jurinke; Dirk van den Boom; Charles R Cantor; Hubert Köster
Journal:  Methods Mol Biol       Date:  2002

2.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

3.  A variant of the IL4 I50V single-nucleotide polymorphism is associated with erosive joint disease in psoriatic arthritis.

Authors:  Proton Rahman; Tara Snelgrove; Lynette Peddle; Fiotos Siannis; Vernon Farewell; Cathy Schentag; Dafna Gladman
Journal:  Arthritis Rheum       Date:  2008-07

4.  Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis.

Authors:  Iryna Prots; Alla Skapenko; Jörg Wendler; Stefan Mattyasovszky; Clarisse L Yoné; Bernd Spriewald; Harald Burkhardt; Rolf Rau; Joachim R Kalden; Peter E Lipsky; Hendrik Schulze-Koops
Journal:  Arthritis Rheum       Date:  2006-05

5.  An efficient procedure for genotyping single nucleotide polymorphisms.

Authors:  S Ye; S Dhillon; X Ke; A R Collins; I N Day
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

6.  Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis.

Authors:  J E Hollis-Moffatt; M E Merriman; R A Rodger; K A Rowley; P T Chapman; N Dalbeth; P J Gow; A A Harrison; J Highton; P B B Jones; J L O'Donnell; L K Stamp; T R Merriman
Journal:  Ann Rheum Dis       Date:  2008-07-22       Impact factor: 19.103

Review 7.  From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited.

Authors:  Katia Boniface; Bianca Blom; Yong-Jun Liu; René de Waal Malefyt
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

8.  The Influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis.

Authors:  Eleanor Korendowych; Jonathan Dixey; Beverly Cox; Sharon Jones; Neil McHugh
Journal:  J Rheumatol       Date:  2003-01       Impact factor: 4.666

9.  HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis.

Authors:  Pauline Y P C Ho; Anne Barton; Jane Worthington; Wendy Thomson; Alan J Silman; Ian N Bruce
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

10.  Association between the PTPN22 +1858 C/T polymorphism and psoriatic arthritis.

Authors:  Kristina Juneblad; Martin Johansson; Solbritt Rantapää-Dahlqvist; Gerd-Marie Alenius
Journal:  Arthritis Res Ther       Date:  2011-03-16       Impact factor: 5.156

View more
  10 in total

1.  IL17RA gene variants and anti-TNF response among psoriasis patients.

Authors:  A Batalla; E Coto; J Gómez; N Eirís; D González-Fernández; C Gómez-De Castro; E Daudén; M Llamas-Velasco; R Prieto-Perez; F Abad-Santos; G Carretero; F S García; Y B Godoy; L F Cardo; B Alonso; S Iglesias; P Coto-Segura
Journal:  Pharmacogenomics J       Date:  2016-09-27       Impact factor: 3.550

Review 2.  New treatments for inflammatory rheumatic disease.

Authors:  Carlo Selmi; Elena Generali; Marco Massarotti; Gerolamo Bianchi; Carlo A Sciré
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

3.  Association between IL-17A, IL-17F and IL-17RA gene polymorphisms and susceptibility to psoriasis and psoriatic arthritis: a meta-analysis.

Authors:  Fridha Viridiana Villalpando-Vargas; Juan José Rivera-Valdés; Anabell Alvarado-Navarro; Selene Guadalupe Huerta-Olvera; José Macías-Barragán; Erika Martínez-López; Omar Graciano-Machuca
Journal:  Inflamm Res       Date:  2021-10-27       Impact factor: 4.575

4.  A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis.

Authors:  Jose Ramón Vidal-Castiñeira; Antonio López-Vázquez; Roberto Diaz-Peña; Paula Diaz-Bulnes; Pablo Martinez-Camblor; Eliecer Coto; Pablo Coto-Segura; Jacome Bruges-Armas; Jose Antonio Pinto; Francisco Jose Blanco; Alejandra Sánchez; Juan Mulero; Ruben Queiro; Carlos Lopez-Larrea
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

5.  Influence of TNF and IL17 Gene Polymorphisms on the Spondyloarthritis Immunopathogenesis, Regardless of HLA-B27, in a Brazilian Population.

Authors:  Marco A Rocha Loures; Luciana C Macedo; Denise M Reis; Camila F Oliveira; Jean L Meneguetti; Gabriela F Martines; Janisleya S F Neves; Eliana de Souza; Ana M Sell; Jeane E L Visentainer
Journal:  Mediators Inflamm       Date:  2018-04-19       Impact factor: 4.711

6.  Association of IL-17 and IL-23 Gene Variants with Plasma Levels and Risk of Vulvovaginal Candidiasis in a Chinese Han Population.

Authors:  Wei Li; Wenyin Shi; Yujun Yin; Juan Chen; Lanlan Luo
Journal:  Pharmgenomics Pers Med       Date:  2020-12-15

Review 7.  Influence of Genetic Polymorphisms on Response to Biologics in Moderate-to-Severe Psoriasis.

Authors:  Cristina Membrive Jiménez; Cristina Pérez Ramírez; Almudena Sánchez Martín; Sayleth Vieira Maroun; Salvador Antonio Arias Santiago; María Del Carmen Ramírez Tortosa; Alberto Jiménez Morales
Journal:  J Pers Med       Date:  2021-04-12

8.  Evaluation of the relationship of IL-17A and IL-17F gene polymorphisms with the response to treatment in psoriatic patients using biological drugs: a case-control study in patients in Eastern Turkey.

Authors:  Hatice Uce Ozkol; Gokhan Gorgisen; Can Ates; Halil Özkol; Yasin Tülüce; Hulya Savas; İsmail Musab Gulacar
Journal:  Postepy Dermatol Alergol       Date:  2020-05-26       Impact factor: 1.837

9.  Polymorphisms within Genes Coding for IL-17A and F and Their Receptor as Clinical Hallmarks in Ankylosing Spondylitis.

Authors:  Joanna Wielińska; Jerzy Świerkot; Katarzyna Kolossa; Bartosz Bugaj; Monika Chaszczewska-Markowska; Sławomir Jeka; Katarzyna Bogunia-Kubik
Journal:  Mediators Inflamm       Date:  2021-10-27       Impact factor: 4.711

10.  Genetic association of IL2RA, IL17RA, IL23R, and IL31RA single nucleotide polymorphisms with alopecia areata.

Authors:  Mansour A Alghamdi; Laith N Al-Eitan; Hanan A Aljamal; Ayed A Shati; Mohammed A Alshehri
Journal:  Saudi J Biol Sci       Date:  2022-09-27       Impact factor: 4.052

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.